212 related articles for article (PubMed ID: 16508724)
1. Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
Shiozawa T; Konishi I
Int J Clin Oncol; 2006 Feb; 11(1):13-21. PubMed ID: 16508724
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer during pregnancy: management strategies.
Eriksson AG; Fallaas Dahl G; Nesbakken AJ; Lund KV; Amant F
Int J Gynecol Cancer; 2019 Sep; 29(7):1221-1224. PubMed ID: 31434687
[No Abstract] [Full Text] [Related]
6. Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancer.
Samimi G; Sathyamoorthy N; Tingen CM; Mazloomdoost D; Conroy J; Heckman-Stoddard B; Halvorson LM
Am J Obstet Gynecol; 2020 Dec; 223(6):796-808. PubMed ID: 32835714
[TBL] [Abstract][Full Text] [Related]
7. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic synchronous quintuple primary cancers.
Komiyama S; Nishio E; Ichikawa R; Miyamura H; Kawamura K; Komiyama M; Nishio Y; Udagawa Y
Gynecol Obstet Invest; 2012; 74(4):324-8. PubMed ID: 22776788
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis and treatment of endometrial cancer: progress and controversies.
Denschlag D; Ulrich U; Emons G
Dtsch Arztebl Int; 2010 Aug; 108(34-35):571-7. PubMed ID: 21904591
[TBL] [Abstract][Full Text] [Related]
10. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
Alimena S; Fiascone S; Krasner C; King M; Horowitz N
Curr Probl Cancer; 2019 Oct; 43(5):443-449. PubMed ID: 30770127
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used durıing surveillance.
Simsek SY; Serbetcioglu G; Alemdaroglu S; Yetkinel S; Durdag GD; Celik H
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):473-477. PubMed ID: 31212025
[TBL] [Abstract][Full Text] [Related]
13. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy in endometrial cancer: unfinished business?
Terada K
Ann Oncol; 2012 May; 23(5):1083-1084. PubMed ID: 22115928
[No Abstract] [Full Text] [Related]
15. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
16. Synchronous Well-differentiated Endometrioid Adenocarcinoma and Leiomyosarcoma of the Uterus With Pulmonary Metastasis in a 50-Yr-Old Woman: A Case Report and Review of Literature.
Abbas A; Ud Din N; Kayani N
Int J Gynecol Pathol; 2020 Jul; 39(4):373-378. PubMed ID: 31157684
[TBL] [Abstract][Full Text] [Related]
17. The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma.
Macwhinnie N; Monaghan H
Int J Gynecol Cancer; 2004; 14(5):938-46. PubMed ID: 15361207
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma.
Di Cristofano A; Ellenson LH
Annu Rev Pathol; 2007; 2():57-85. PubMed ID: 18039093
[TBL] [Abstract][Full Text] [Related]
19. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract][Full Text] [Related]
20. Use of mutation profiles to refine the classification of endometrial carcinomas.
McConechy MK; Ding J; Cheang MC; Wiegand K; Senz J; Tone A; Yang W; Prentice L; Tse K; Zeng T; McDonald H; Schmidt AP; Mutch DG; McAlpine JN; Hirst M; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
